1.50
                                            
            Skye Bioscience Inc stock is traded at $1.50, with a volume of 297.72K.
            It is down -3.23% in the last 24 hours and down -68.42% over the past month.
            Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
        
        See More
    Previous Close:
              $1.55
            Open:
              $1.53
            24h Volume:
                297.72K
            Relative Volume:
              0.37
            Market Cap:
                $46.48M
            Revenue:
              -
            Net Income/Loss:
              $-42.37M
            P/E Ratio:
              -1.4037
            EPS:
                -1.0686
            Net Cash Flow:
                $-34.94M
            1W Performance:
              -6.83%
            1M Performance:
              -68.42%
            6M Performance:
                -33.04%
            1Y Performance:
              -73.02%
            Skye Bioscience Inc Stock (SKYE) Company Profile
Name
                  
                      Skye Bioscience Inc
                    
                Sector
                  Industry
                  Phone
                  
                      (858) 410-0266
                    
                Address
                  
                      11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
                    
                Compare SKYE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                SKYE
                            
                             
                        Skye Bioscience Inc. 
                           | 
                    3.10 | 12.89M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                MOBBW
                            
                             
                        Mobilicom Limited Warrants 
                           | 
                    3.17 | 4.40B | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                GOODO
                            
                             
                        Gladstone Commercial Corporation 
                           | 
                    19.96 | 372.90M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                SHMD
                            
                             
                        Schmid Group N V 
                           | 
                    5.05 | 189.47M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                PSNYW
                            
                             
                        Polestar Automotive Holding Uk 
                           | 
                    0.237 | 554.19M | 2.07B | -1.42B | -1.37B | -0.6765 | 
| 
                         
                          
                                DAVEW
                            
                             
                        Dave Inc 
                           | 
                    1.40 | 0 | 0 | 0 | 0 | 0.00 | 
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Oct-06-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral | 
| Oct-06-25 | Downgrade | Craig Hallum | Buy → Hold | 
| Aug-15-25 | Initiated | Evercore ISI | Outperform | 
| Feb-28-25 | Initiated | William Blair | Outperform | 
| Sep-30-24 | Initiated | Scotiabank | Sector Outperform | 
| Sep-10-24 | Initiated | JMP Securities | Mkt Outperform | 
| Jul-09-24 | Initiated | Craig Hallum | Buy | 
| May-23-24 | Initiated | Cantor Fitzgerald | Overweight | 
| Apr-12-24 | Initiated | Oppenheimer | Outperform | 
                    View All
                    
                  
                Skye Bioscience Inc Stock (SKYE) Latest News
Applying big data sentiment scoring on Skye Bioscience Inc.July 2025 Volume & Expert Approved Momentum Ideas - newser.com
Price action breakdown for Skye Bioscience Inc.GDP Growth & Weekly High Conviction Trade Ideas - newser.com
Live market analysis of Skye Bioscience Inc.Weekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Is Skye Bioscience Inc. (09R) stock a momentum leaderJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Is Skye Bioscience Inc. stock a defensive play in 2025Weekly Risk Report & Growth-Oriented Investment Plans - newser.com
How to integrate Skye Bioscience Inc. into portfolio analysis toolsProfit Target & AI Enhanced Trading Alerts - newser.com
Will Skye Bioscience Inc. (09R) stock outperform foreign stocksJuly 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com
Will Skye Bioscience Inc. stock go up soon2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
Why Skye Bioscience Inc. stock appeals to dividend seekersQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Skye Bioscience Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Is Skye Bioscience Inc. forming a reversal patternInsider Selling & Weekly Return Optimization Plans - newser.com
Is Skye Bioscience Inc. still worth holding after the dipJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Volatility clustering patterns for Skye Bioscience Inc.Trade Exit Report & Safe Entry Zone Identification - newser.com
How Skye Bioscience Inc. stock reacts to inflationary pressuresMarket Weekly Review & Momentum Based Trading Ideas - newser.com
Can Skye Bioscience Inc. stock maintain growth trajectoryBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
What technical models suggest about Skye Bioscience Inc.’s comeback - newser.com
How Skye Bioscience Inc. stock performs in weak economyFed Meeting & Daily Growth Stock Tips - newser.com
Intraday pattern recognizer results for Skye Bioscience Inc.GDP Growth & Weekly Market Pulse Updates - newser.com
Will Skye Bioscience Inc. (09R) stock keep raising dividendsJuly 2025 EndofMonth & Community Consensus Stock Picks - newser.com
Is Skye Bioscience Inc a good long term investmentCapital Gains Strategies & Rapid Portfolio Investment - earlytimes.in
Regression analysis insights on Skye Bioscience Inc. performanceGDP Growth & Weekly Market Pulse Alerts - newser.com
What analysts say about Skye Bioscience Inc stockSupport Zone Identification & Ride the Trends That Billionaires Follow - earlytimes.in
Will Skye Bioscience Inc. stock deliver consistent dividendsGold Moves & Fast Exit and Entry Strategy Plans - newser.com
How Skye Bioscience Inc. stock performs during Fed tightening cyclesRate Hike & Weekly Setup with ROI Potential - newser.com
Published on: 2025-10-30 23:45:10 - newser.com
Skye Bioscience Inc Stock (SKYE) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):